Stockscreener 앱 받기
2.86
1.42%
0.04
시간 외 거래:
2.79
-0.07
-2.45%
전일 마감가:
$2.82
열려 있는:
$2.8486
하루 거래량:
50,708
Relative Volume:
0.02
시가총액:
$2.28M
수익:
$12,400
순이익/손실:
$-5.03M
주가수익비율:
-0.1691
EPS:
-16.9112
순현금흐름:
$-4.87M
1주 성능:
-4.03%
1개월 성능:
-23.53%
6개월 성능:
-44.63%
1년 성능:
-84.49%
1일 변동 폭
$2.78
$2.89
1주일 범위
$2.71
$2.99
52주 변동 폭
$2.50
$21.75
Virax Biolabs Group Ltd Stock (VRAX) Company Profile
Compare VRAX vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VRAX
Virax Biolabs Group Ltd
|
2.86 | 2.22M | 12,400 | -5.03M | -4.87M | -16.91 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Virax Biolabs Group Ltd Stock (VRAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-31 | 개시 | H.C. Wainwright | Buy |
Virax Biolabs Group Ltd 주식(VRAX)의 최신 뉴스
Virax Biolabs Group Ltd (VRAX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Virax Biolabs and Transcode Therapeutics Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV - ACCESS Newswire
Alliance Entertainment and Virax Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire
Virax Biolabs Calls August 14 EGM to Approve Major Share Capital Increase - TipRanks
Virax Biolabs Group Ltd (VRAX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Virax Biolabs Group Ltd (VRAX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Virax Biolabs Group Ltd (VRAX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
VRAX|Virax Biolabs Group Ltd|Price:3.140|Chg%:-0.050 - TradingKey
VRAX|Virax Biolabs Group Ltd|Price:3.050|Chg%:-0.140 - TradingKey
Virax Biolabs Group Ltd (VRAX) Valuation: PE, PB & Fair Value Analysis - TradingKey
VRAX|Virax Biolabs Group Ltd|Price:2.620|Chg%:-0.180 - TradingKey
Virax Biolabs Group Ltd (VRAX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Virax Biolabs Group Ltd (VRAX) Cash Flow - TradingKey
Virax Biolabs Group Ltd (VRAX) Income Statement - TradingKey
Virax Biolabs Group Ltd (VRAX) Balance Sheet - TradingKey
Virax Biolabs Company Profile & Introduction - Moomoo
Virax Biolabs (Nasdaq: VRAX) files F-3 to register 1.68M warrant shares - Stock Titan
VRAX SEC FilingsVirax Biolabs Group Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Virax Biolabs Boosts Liquidity, Secures Fosun Deal and Restores Nasdaq Compliance After Fiscal 2026 Report - The Globe and Mail
บทสัมภาษณ์ของ Avalon Advanced Materials และ Virax Biolabs เตรียมออกอากาศในรายการ RedChip Small Stocks, Big Money(TM) ทางช่อง Bloomberg TV - Moomoo
Virax Biolabs signs Fosun Diagnostics supply deal for ImmuneSelect in six Southeast Asian markets - Bitget
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Sahm
Virax Biolabs reports $6.4m cash, regains Nasdaq compliance By Investing.com - Investing.com Australia
Get insights into the top gainers and losers of Thursday's pre-market session. - ChartMill
Virax Biolabs (NASDAQ: VRAX) boosts cash, secures Fosun deal and regains Nasdaq bid compliance - Stock Titan
Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement - Moomoo
Virax Biolabs' ImmuneSelect Supply Deal Reaches Six Southeast Asian Markets - Stock Titan
Virax Biolabs enters immune profiling product supply deal with Fosun - Yahoo Finance
Dow Gains 50 Points; Simulations Plus Earnings Top Views - Benzinga
US Stocks Edge Higher; Delta Air Lines Posts Upbeat Q2 Earnings - Sahm
Virax Biolabs Raises $3.3 Million via Exercise of Investment Options and Issues New Warrants - TipRanks
Virax Biolabs : Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds - marketscreener.com
Virax Biolabs (Nasdaq: VRAX) secures $3.3M and issues new equity warrants - Stock Titan
$3.3M cash in, new Virax Biolabs warrants out at $6 a share - Stock Titan
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
The market is filled with gapping stocks in Friday's session. - ChartMill
Top Premarket Decliners - Moomoo
These stocks that are showing activity before the opening bell on Friday. - ChartMill
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Thursday's after hours session: top gainers and losers - ChartMill
Virax Biolabs Stock Skyrockets 100% on Exclusive Distribution Agreement - Yahoo Finance
Virax Biolabs secures $3.3m from warrant exercise By Investing.com - Investing.com South Africa
Thursday's session: most active stocks - ChartMill
Virax Biolabs locks in $3.3M from option exercise deal - Stock Titan
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Virax Biolabs signs supply deal with Fosun Diagnostics By Investing.com - Investing.com India
Gold Gains Over 1%; PepsiCo Shares Fall After Q2 Results - Benzinga
Virax Biolabs Jumps on Fosun Diagnostics Supply Agreement - Quiver Quantitative
Virax Biolabs (VRAX) Stock Explodes 241% on Fosun Diagnostics Partnership - parameter.io
Virax Biolabs (VRAX) Stock Rockets 241% on Fosun Diagnostics Partnership - Blockonomi
Virax Biolabs Group Ltd (VRAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
0.07%
자본화:
|
볼륨(24시간):